APA-viite

Park, H. B., Lee, J. E., Oh, Y. M., Lee, S. J., Eom, H., & Choi, K. (2017). CTLA4-CD28 chimera gene modification of T cells enhances the therapeutic efficacy of donor lymphocyte infusion for hematological malignancy. Exp Mol Med.

Chicago-tyylinen lähdeviittaus

Park, Hyung Bae, Ji Eun Lee, Yu Mi Oh, Sang Jin Lee, Hyeon-Seok Eom, ja Kyungho Choi. "CTLA4-CD28 Chimera Gene Modification of T Cells Enhances the Therapeutic Efficacy of Donor Lymphocyte Infusion for Hematological Malignancy." Exp Mol Med 2017.

MLA-viite

Park, Hyung Bae, et al. "CTLA4-CD28 Chimera Gene Modification of T Cells Enhances the Therapeutic Efficacy of Donor Lymphocyte Infusion for Hematological Malignancy." Exp Mol Med 2017.

Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.